https://hemogenyx.com/videos/investival-conference-presentation-november-19-2019/2023-09-18T22:13:33+01:00https://hemogenyx.com/videos/explainer-series-2-hemogenyx-pharmaceuticals-introduction-2/2023-09-18T21:53:55+01:00https://hemogenyx.com/videos/explainer-series-1-hemogenyx-pharmaceuticals-introduction-1/2023-09-18T21:54:14+01:00https://hemogenyx.com/videos/fundraise-announcement-12-may-2020/2023-09-18T21:54:35+01:00https://hemogenyx.com/videos/development-agreement-for-autoimmune-diseases/2023-09-18T21:54:53+01:00https://hemogenyx.com/videos/financing-facility-trading-update/2023-09-18T21:55:31+01:00https://hemogenyx.com/videos/ash-2020-presentation-cdx-antibody/2023-09-18T21:55:47+01:00https://hemogenyx.com/videos/investor-webinar-6-july-2022/2023-09-18T22:12:33+01:00https://hemogenyx.com/videos/hemogenyx-pharmaceuticals-overview-2023/2024-04-17T21:45:42+01:00https://hemogenyx.com/videos/proactive-investors-hemogenyx-pharmaceuticals-achieves-breakthrough-with-hemo-car-t-program-cbr-platform/2024-04-17T20:47:09+01:00https://hemogenyx.com/videos/proactive-investors-hemogenyx-pharmaceuticals-discusses-successful-3-5m-capital-raise-as-it-advances-hemo-car-t-program/2024-04-17T20:39:18+01:00https://hemogenyx.com/videos/hemogenyx-pharmaceuticals-ceo-discusses-progress-across-clinical-programs/2024-06-27T15:53:30+01:00